WHETHER DYSLIPIDEMIA PLAYS THE PATHOGENETIC ROLE IN THE DEVELOPMENT OF NONINFLAMMATORY CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME?


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The study examined symptomatology in 74 patients with chronic abacterial prostatitis. The features of blood lipid metabolism in inflammatory and noninflammatory forms of disease are redefined. Dynamic characteristics of arterial blood flow in the prostate gland of patients with chronic abacterial prostatitis are determined. Comparative analysis between groups revealed significant differences in some indices of blood lipid profile, and arterial flow velocity parameters of the prostate in patients studied; correlations between the intensity of pain, the type of dyslipoproteinemia and arterial ischemia of the prostate are shown. The feasibility of analysis of the blood lipoprotein spectrum in the differential diagnosis of inflammatory and noninflammatory forms of chronic abacterial prostatitis is demonstrated.

Full Text

Restricted Access

References

  1. Nickel J. C., Shoskes D., Wang Y. et al. How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome? J. Urol. 2006; 176(1): 119-124.
  2. Shoskes D. A. Chronic Prostatitis/Chronic Pelvic Pain Syndrome. Humana Press. 2008;346.
  3. Schaeffer A. J., Landis J. R., Knauss J. S. et al. Demographic and clinical characteristics of men with chronic prostatitis: the National Institutes of Health chronic prostatitis cohort study. J. Urol. 2002; 168: 593-598.
  4. Nickel J. C., Alexander R. B., Schaeffer A. J. et al. Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls. J. Urol. 2003;170: 818-822.
  5. Krieger J., Nyberg Z., Nickel I. NIH-consensus definition and classification of prostatitis. JAMA. 1999;282:236-237.
  6. Luzzi G., Schaeffer A. J. Chronic Prostatitis. NEJM. 2007; 356:423-424.
  7. Downey J., Nickel J. C., Pontari M. A. et al. Randomized placebo controlled multi center pilot study to evaluate the safety and efficacy of finasteride in the treatment of male CPPS: category IIIA. J. Urol. 2002; 167(Suppl.):26.
  8. Propert K. J., Alexander R. B., Nickel J. C. et al. Design of a multicenter randomized clinical trial for CP/CPPS. J. Urology. 2002;59: 870-876.
  9. Forrest John B., Schmidt. Sunshine. J. Urol. 2004; 172(6, Part 2 of 2):2561-2562.
  10. Pavone-Macaluso M. Chronic prostatitis syndrome: a common, but poorly understood condition. Part I. EAU-EBU Update Series. 2007; 5: 1-15.
  11. Kogan M., Belousov I., Shangichev A. et al. Transrectal color Doppler imaging in chronic prostatitis IIIB. Ultrasound in Medicine & Biology. 2006;32(5):97.
  12. Kogan M., Belousov I., Shangichev et al. Relationship of Low Urinary Tract Symptoms and Chronic Pelvic Pain Syndrome in men with Pelvic Hemodynamic Disorders. Eur. Urol. 2009; 8(4 Suppl.):258.
  13. Kogan M., Mikashinovich Z., Belousov I. et al. The study of antioxidant defens system components activity in patients with Chronic Pelvic Pain Syndrome. In Book of abstracts VIth International Consultation on New Developments in Prostate Cancer and Prostate Diseases. Paris. 2005; 32.
  14. Kogan M., Mikashinovich Z., Belousov I. et al. The study of kallicreinkinin system components activity in patients with Chronic Pelvic Pain Syndrome. Eur. Urol. 2005;4(3 Suppl.):95.
  15. Диагностика и коррекция нарушений липидного обмена с целью профилактики и лечения атеросклероза. Российские рекомендации (IV пересмотр). Кардиоваскулярная терапия и профилактика. 2009;8(6 Прил. 3).
  16. Catapano A. L., Reiner Ž., DeBacker G. et al. ESC/EAS Guidelines for the management of dyslipidaemias: The T ask Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis. 2011; 217(Suppl. 1):1—44.
  17. Litwin M. S., McNaughton, Collins M., Fowler F. J. et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol. 1999; 162(2):369-375.
  18. Rosen R. C., Cappelleri J. C., Smith M. D. et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int. J. Impot. Res. 1999;11(6):319-326.
  19. Warnick G. R. et al. Selected Methods of Clinical Chemistry. Gerald R. Cooper Ed. 1983;10:91-99.
  20. Реброва О. Ю. Статистический анализ медицинских данных. М.: Гэотар-Мед; 2003;139.
  21. Kogan M., Belousov I., Matcionis A. et al. “Chronic Ishemic Disease” of the prostate based on the results of transrectal biopsy of the prostate in Chronic Pelvic Pain syndrome IIIB. Eur. Urol. 2010; 9(2 Suppl.):137.
  22. Azadzoi K. M., Chen B. G., Radisavljevic Z. M. et al. Molecular reactions and ultrastructural damage in the chronically ischemic bladder. J. Urol. 2011;186(5):2115-2122.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies